About Johns Hopkins

Recent news from The Johns Hopkins University

This section contains regularly updated highlights of the news from around The Johns Hopkins University. Links to the complete news reports from the nine schools, the Applied Physics Laboratory and other centers and institutes are to the left, as are links to help news media contact the Johns Hopkins communications offices.

 

Johns Hopkins Experts Available to Discuss CDC, FDA Suspension of Johnson & Johnson Vaccine

Federal health agencies have asked for a temporary distribution suspension of the Johnson & Johnson vaccine after instances of blood clots linked to the shots. The decision is expected to halt or limit U.S. rollout of the vaccine, and Johns Hopkins University experts can offer perspective and commentary on the news.

Johns Hopkins Releases Comprehensive Report on Digital Contact Tracing to Aid COVID-19 Response

Johns Hopkins University today released a comprehensive report to help government, technology developers, businesses, institutional leaders and the public make responsible decisions around use of digital contact tracing technology (DCTT), including smartphone apps and other tools, to fight COVID-19.

MEDIA ADVISORY: JHU Expert Available on Implications of 3-Parent Baby

A 32-year-old Greek woman is reportedly pregnant from an experimental reproductive technique that uses DNA from three people, the result of the first known clinical trial to use the controversial procedure to treat infertility. 

Jeffrey Kahn, director of Johns Hopkins University’s Berman Institute of Bioethics, who chaired a 2016 U.S. National Academy of Sciences panel that examined the science and ethical issues raised by the three-parent procedure, is available to discuss the implications of this new pregnancy and the procedure, known as mitochondrial replacement therapy, which is banned in the United States.